Starting this Thread to demonstrate the upcoming year of Trials ahead for Pharmaust.
The title says it all.
Human Covid Trial , Multiple Clinics in discussion with PAA adding to the pool of positive data gained from WEHI from 2 Independent Trials, Biolabs 360 and the Leiden University in Holland.
MPL in the Lab demonstrated that MPL can reduce the Viral Load by 50% in the first 24 hours and 95% over the coming 72 hours,,
This Trial should be short and swift and from the reputation of the above institutes the results will be replicable.
Leading to a safe robust Treatment that should reduce Hospitalisation times and assist those that have contracted Covid and possibly the entire SARs-1 and SARs-2 family, this would be a breakthrough Treatment.
MND Motor Neuron Disease , Fully Funded by MND Australia
K9 Phase III , specialist negotiator brought on board to secure a Phase III K9 Lymphoma Trial Partner or early Commercial Deal.
The Company already has solid confirmation of the benefits of MPL and now wish to trial with a companion drug to increase the benefits to K9's , this data will be utilised for the upcoming Human Trials.
Human Oncology , PAA intend to replicate the Positive Results from the 2016 Human Cancer Trial negating any of the previous minor adverse effects. This will be a "Take at Home" cancer treatment with no harmful adverse side effects negating the use of aggressive Chemotherapy.
HVTL-1 Based Virus the cousin of HIV and a precursor to Leukemia ,WEHI identified Positive effect of MPL.
The company are awaiting the delivery of refined and micronised MPL , "Pharmapantel" the Tablets/Pill has been designed to be very small to reduce patient burden and easier to swallow.
2022 is Pharmausts year in the Spotlight , NZT
- Forums
- ASX - By Stock
- PAA
- PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
- There are more pages in this discussion • 1,466 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $94.80M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 23.5¢ | $140.9K | 586.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12010 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 70000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12010 | 0.240 |
2 | 30525 | 0.235 |
10 | 116000 | 0.230 |
5 | 192316 | 0.225 |
6 | 236160 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 70000 | 1 |
0.250 | 15000 | 1 |
0.255 | 85000 | 3 |
0.260 | 111500 | 3 |
0.265 | 134833 | 4 |
Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
Last
23.5¢ |
  |
Change
-0.010 ( 4.08 %) |
|||
Open | High | Low | Volume | ||
24.0¢ | 24.5¢ | 23.5¢ | 164909 | ||
Last updated 15.58pm 26/04/2024 ? |
Featured News
PAA (ASX) Chart |